drugset / Trial / NCT01785043

Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users

NCT01785043

Phase 4 Completed 13 enrolled Anna Cruceta
RandomizedParallel-groupOpen-labelTreatment

Summary

Differences in endothelial function amongst Sitagliptin and Liraglutide Users. A randomized, open-label, parallel-group and active controlled trial

Timeline

Start
2013-03
Primary completion
2014-03
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Liraglutide Peptide 1.8 mg Subcutaneous
Comparator Sitagliptin Small molecule 100 mg Oral